Literature DB >> 7710932

The interaction with tubulin of a series of stilbenes based on combretastatin A-4.

J A Woods1, J A Hadfield, G R Pettit, B W Fox, A T McGown.   

Abstract

A series of stilbenes, based on combretastatin A-4, were synthesised. A structure-activity study was carried out to characterise the interaction of these agents with tubulin. The substitution of small alkyl substituents for the 4'-methoxy group of combretastatin A-4 and the loss of the 3'-hydroxyl group does not have a major effect on the interaction with tubulin. trans-Stilbenes were shown to bind tubulin, but do not inhibit microtubule assembly. This work, together with previous studies, has been used to propose an idealised structure for a tubulin-binding agent of this type.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7710932      PMCID: PMC2033763          DOI: 10.1038/bjc.1995.138

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  Immunofluorescence of mitotic spindles by using monospecific antibody against bovine brain tubulin.

Authors:  G M Fuller; B R Brinkley; J M Boughter
Journal:  Science       Date:  1975-03-14       Impact factor: 47.728

2.  Initial studies on maytansine-induced metaphase arrest in L1210 murine leukemia cells.

Authors:  M K Wolpert-DeFilippes; V H Bono; R L Dion; D G Johns
Journal:  Biochem Pharmacol       Date:  1975-09-15       Impact factor: 5.858

3.  Differential cytotoxicity of combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines.

Authors:  A T McGown; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.

Authors:  G R Pettit; S B Singh; E Hamel; C M Lin; D S Alberts; D Garcia-Kendall
Journal:  Experientia       Date:  1989-02-15

5.  Synthesis and evaluation of analogues of (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents.

Authors:  M Cushman; D Nagarathnam; D Gopal; H M He; C M Lin; E Hamel
Journal:  J Med Chem       Date:  1992-06-12       Impact factor: 7.446

6.  Interaction of vinblastine with calf brain tubulin: multiple equilibria.

Authors:  G C Na; S N Timasheff
Journal:  Biochemistry       Date:  1986-10-07       Impact factor: 3.162

7.  The interaction of vincristine with calf brain tubulin.

Authors:  V Prakash; S N Timasheff
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

8.  Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum.

Authors:  G R Pettit; S B Singh; M L Niven; E Hamel; J M Schmidt
Journal:  J Nat Prod       Date:  1987 Jan-Feb       Impact factor: 4.050

9.  Structural and biochemical comparison of the anti-mitotic agents colchicine, combretastatin A4 and amphethinile.

Authors:  A T McGown; B W Fox
Journal:  Anticancer Drug Des       Date:  1989-03

10.  Microtubular protein impairment by pentanal and hexanal.

Authors:  A Miglietta; L Gabriel; E Gadoni
Journal:  Cell Biochem Funct       Date:  1987-07       Impact factor: 3.685

  10 in total
  25 in total

1.  Screening for main components associated with the idiosyncratic hepatotoxicity of a tonic herb, Polygonum multiflorum.

Authors:  Chunyu Li; Ming Niu; Zhaofang Bai; Congen Zhang; Yanling Zhao; Ruiyu Li; Can Tu; Huifang Li; Jing Jing; Yakun Meng; Zhijie Ma; Wuwen Feng; Jinfa Tang; Yun Zhu; Jinjie Li; Xiaoya Shang; Zhengsheng Zou; Xiaohe Xiao; Jiabo Wang
Journal:  Front Med       Date:  2017-03-17       Impact factor: 4.592

2.  Correlation of hydrogen-bonding propensity and anticancer profile of tetrazole-tethered combretastatin analogues.

Authors:  Ganesh S Jedhe; Debasish Paul; Rajesh G Gonnade; Manas K Santra; Ernest Hamel; Tam Luong Nguyen; Gangadhar J Sanjayan
Journal:  Bioorg Med Chem Lett       Date:  2013-06-12       Impact factor: 2.823

3.  Biosynthesis of the major tetrahydroxystilbenes in spruce, astringin and isorhapontin, proceeds via resveratrol and is enhanced by fungal infection.

Authors:  Almuth Hammerbacher; Steven G Ralph; Joerg Bohlmann; Trevor M Fenning; Jonathan Gershenzon; Axel Schmidt
Journal:  Plant Physiol       Date:  2011-08-24       Impact factor: 8.340

4.  Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents.

Authors:  D J Chaplin; G R Pettit; C S Parkins; S A Hill
Journal:  Br J Cancer Suppl       Date:  1996-07

5.  The ultra-performance liquid chromatography tandem mass spectrometry method for detection and quantification of C4NP in rat plasma and its application to pharmacokinetic studies.

Authors:  J You; L Wang; F Yang; J Shang
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

6.  Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.

Authors:  Narsimha Reddy Penthala; Hongliang Zong; Amit Ketkar; Nikhil Reddy Madadi; Venumadav Janganati; Robert L Eoff; Monica L Guzman; Peter A Crooks
Journal:  Eur J Med Chem       Date:  2014-12-29       Impact factor: 6.514

Review 7.  A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P).

Authors:  Dietmar W Siemann; David J Chaplin; Patricia A Walicke
Journal:  Expert Opin Investig Drugs       Date:  2009-02       Impact factor: 6.206

8.  Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization.

Authors:  Haichan Niu; Tracy E Strecker; Jeni L Gerberich; James W Campbell; Debabrata Saha; Deboprosad Mondal; Ernest Hamel; David J Chaplin; Ralph P Mason; Mary Lynn Trawick; Kevin G Pinney
Journal:  J Med Chem       Date:  2019-05-24       Impact factor: 7.446

9.  Hepatocellular Carcinoma: Intra-arterial Delivery of Doxorubicin-loaded Hollow Gold Nanospheres for Photothermal Ablation-Chemoembolization Therapy in Rats.

Authors:  Junjie Li; Min Zhou; Fengyong Liu; Chiyi Xiong; Wanqin Wang; Qizhen Cao; Xiaoxia Wen; J David Robertson; Xin Ji; Y Andrew Wang; Sanjay Gupta; Chun Li
Journal:  Radiology       Date:  2016-06-27       Impact factor: 11.105

Review 10.  The biology of the combretastatins as tumour vascular targeting agents.

Authors:  Gillian M Tozer; Chryso Kanthou; Charles S Parkins; Sally A Hill
Journal:  Int J Exp Pathol       Date:  2002-02       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.